Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/Amlodipine vs Losartan in Stage 2 Systolic Hypertension
NCT00931710Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of valsartan and amlodipine in isolated systolic hypertension (ISH) (2 arms), sponsored by Novartis. Primary endpoint: Change in Mean Sitting Systolic Blood Pressure After 6 Weeks. Started Jul 2009; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on NCT00931710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931710.